Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 18, 15:45
443.80
-2.5 (-0.56%)
VOLUME 124,404
LIVE
NSE
Oct 18, 15:59
444.15
-2.15 (-0.48%)
VOLUME 2,850,227
Announcements on Cipla

18th-Oct-2019 15:05Source: BSE

Cipla- Earnings Conference Call

The Company will host an Earnings conference call at 1700 hrs IST (1930 hrs SST/HKT, 1230 hrs BST, 0730 hrs US ET), during which the leadership team will discuss the financial performance and take que...

18th-Oct-2019 13:28Source: BSE

Cipla- Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor compl...

17th-Oct-2019 19:54Source: BSE

Cipla- Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

We are enclosing herewith Compliance Certificate, duly signed by the Compliance Officer of the Company and the Registrar and Share Transfer Agent, Karvy Fintech Private Limited (SEBI Registration No. ...

17th-Oct-2019 19:32Source: BSE

Cipla- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed press release dated 17th October, 2019, regarding acquisition of a novel and patented anti-infective asset, Elores, from Venus Remedies Limited.

28th-Sep-2019 13:13Source: BSE

Cipla- USFDA Cgmp Inspection Completed At Cipla''s Manufacturing Facility In Goa

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the United States Food and Drug Administration (USFDA) conducted a...

25th-Sep-2019 19:43Source: BSE

Cipla- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release - Cipla announces the launch of Daptomycin for injection, 500 mg/vial, single-dose vials (for intravenous use only)

25th-Sep-2019 17:37Source: BSE

Cipla- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Schedule of Analyst /Institutional Investor Meeting of the Company

22nd-Sep-2019 15:53Source: BSE

Cipla- Closure Of USFDA Inspection At API Manufacturing Facility In Virgonagar

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that following the inspection by the United States Food and Drug Admini...

19th-Sep-2019 15:19Source: NSE

Cipla Limited

Cipla Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

19th-Sep-2019 15:00Source: BSE

Cipla- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Please find enclosed schedule of analyst / institutional investor meetings of the Company

1 2 3 4 5 Next >>
Board Meeting (Cipla)

Meeting Date

Remark

2019-11-06

Quarterly Results

Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.